Ray Dalio, Jim Simons, and Paul Tudor Jones are battling it out over the Magnificent 7
For our last in this week's 13F series, we thought we'd examine three great investors in one fell swoop. The reason we are analysing these three investors is because all of them are making big bets in one specific theme - the Magnificent Seven mega-cap tech stocks. But none of them are making identical moves to each other.
Bridgewater Associates Founder (and former CIO) Ray Dalio is famed for his views on geopolitics, and macroeconomics, and for inventing the "All Weather" approach to investing. His largest holdings appear to reflect that - a barbell bet between a major emerging markets ETF and an ETF tracking the S&P 500. But at the individual stock level, Dalio has made two moves inside the Magnificent Seven. Dalio's latest 13F filing has 740 holdings.
Meanwhile, veteran technical trader Paul Tudor Jones is one to hedge his bets. Not only does he have more than 2,200 holdings according to his latest 13F filing, but he also likes to make trades - often. Between newly initiated put options, call options, and regular long positions, Tudor Jones made 673 moves between the current reporting period and the previous reporting period. That's a lot of movement. He's also been making moves in the Magnificent Seven - and several stand out.
Finally, famed quantitative trader and mathematician Jim Simons has made his fair share of moves. More than 3,600 holdings are in his 13F filing and Simons used last quarter to buy and sell many of the Magnificent Seven names. But his largest individual holding isn't a Magnificent Seven name.
Without further ado, here are the three final investors in our series and their major 13F filings.
Ray Dalio's Q3 13F - Major Buys
Stock Name | Stock Code | Portfolio Addition (%) |
Schlumberger Ltd. | NASDAQ: SLB | 0.28% |
Broadcom | NASDAQ: AVGO | 0.27% |
Netflix | NASDAQ: NFLX | 0.22% |
Meta Platforms | NASDAQ: META | 0.18% |
Cisco Systems | NASDAQ: CSCO | 0.17% |
Ray Dalio's Q3 13F - Major Sells
Stock Name | Stock Code | Portfolio Subtraction (%) |
Johnson & Johnson Co | NASDAQ: JNJ | 0.69% |
Vanguard EM ETF | NYSE: VWO | 0.56% |
Visa | NYSE: V | 0.31% |
Starbucks | NASDAQ: SBUX | 0.27% |
SPDR S&P 500 ETF Trust | ASX: SPY | 0.26% |
Ray Dalio's Top 5 Holdings
Stock Name | Stock Code | Portfolio Allocation (%) |
iShares Core MSCI EM ETF | NYSE: IEMG | 5.52% |
iShares Core S&P 500 ETF | NYSE: IVV | 5.31% |
Procter & Gamble | NYSE: PG | 4.23% |
Coca Cola | NYSE: KO | 3.04% |
Costco | NASDAQ: COST | 2.83% |
Key Takeaway: Dalio appears to be leaning into the EM and Big Tech trades but continues to prefer consumer staples. In the last quarter, two of his major buys were Netflix and Meta Platforms while a third - Broadcom - is considered one of the top ways to play the semiconductor trade. I wonder what Michael Burry would say to that.
In its place, Dalio has sold Johnson & Johnson but kept Procter & Gamble, Coca-Cola, and Costco. As the Danish analyst Andreas Steno Larsen has been known to say, "go long what people need, go short what people want."
Paul Tudor Jones' Q3 13F - Major Buys
Stock Name | Stock Code | Portfolio Addition (%) | Note: |
Activision Blizzard | NASDAQ: ATVI | 2.40% | |
Seagen | NYSE: SGEN | 2.29% | (PUT) |
Invesco QQQ Trust | NYSE: QQQ | 1.80% | |
Seagen | NYSE: SGEN | 1.71% | (LONG) |
Splunk | NASDAQ: SPLK | 1.69% |
Paul Tudor Jones' Q3 13F - Major Sells
Stock Name | Stock Code | Portfolio Subtraction (%) | Note: |
NVIDIA | NASDAQ: NVDA | 4.42% | (CALL) |
Life Storage | NYSE: LSI | 0.87% | |
NVIDIA | NASDAQ: NVDA | 0.84% | (LONG) |
Meta Platforms | NASDAQ: META | 0.68% | |
Alphabet | NASDAQ: GOOGL | 0.62% |
Paul Tudor Jones' Top Holdings
Stock Name | Stock Code | Portfolio Allocation (%) | Note |
Seagen | NYSE: SGEN | 2.98% | (PUT) |
Activision Blizzard | NASDAQ: ATVI | 2.85% | |
Seagen | NYSE: SGEN | 2.49% | (LONG) |
Invesco QQQ Trust | NYSE: QQQ | 1.80% | (CALL) |
Splunk Inc | NASDAQ: SPLK | 1.69% |
Key Insight: Paul Tudor Jones' filings are far more complicated. Not least because, like many technical and quant traders, Tudor Jones uses put and call options which makes compiling this list more challenging.
The two big things for my money are the off-loading in NVIDIA stock and the fact that he's selling Meta when Ray Dalio is buying it. It should be said that Tudor Jones is not known for his short investing, so the NVIDIA call option sale maybe because it's reached his price target (aka, he wants to take his profits while he can).
Jim Simons Q3 13F - Major Buys
Stock Name | Stock Code | Portfolio Addition (%) |
Microsoft | NASDAQ: MSFT | 0.60% |
Berkshire Hathaway | NASDAQ: BRK/A | 0.60% |
Netflix | NASDAQ: NFLX | 0.59% |
Vertex Pharmaceuticals | NASDAQ: VRTX | 0.34% |
Nike | NYSE: NKE | 0.32% |
Jim Simons' Q3 13Fs - Major Sells
Stock Name | Stock Code | Portfolio Subtraction (%) |
Meta Platforms | NASDAQ: META | 1.82% |
Tesla | NASDAQ: TSLA | 0.48% |
Alphabet | NASDAQ: GOOGL | 0.39% |
Boeing | NYSE: BA | 0.38% |
Lululemon | NASDAQ: LULU | 0.32% |
Jim Simons' Top Holdings
Stock Name | Stock Code | Portfolio Allocation (%) |
Novo-Nordisk A/S ADS | CPH: NOVO-B | 2.52% |
Apple | NASDAQ: AAPL | 1.23% |
Palantir | NYSE: PLTR | 1.19% |
VeriSign | NASDAQ: VRSN | 1.07% |
Berkshire Hathaway | NASDAQ: BRK/A | 1.05% |
Key Insight: Several things stand out in this list. Just like Tudor Jones, Jim Simons has been selling Meta Platforms and Alphabet - so much so that it was his top sell and third-largest sell by portfolio allocation last quarter respectively. But unlike Tudor Jones and like Dalio, Simons has shifted some cash into Netflix.
The company has continued to beat (low) earnings and paid subscriber expectations from analysts, allowing the share price to surge from beaten-down levels.
Finally, Simons' largest holding is one that does not sound like the other two. Novo Nordisk has gained a lot of attention in recent months as the manufacturer of Ozempic, the diabetes treatment that has garnered a lot of press around the world for its high demand (by diabetics and non-diabetics).
Note: To see the entire 13F filings of our profiled investors, you can go to 13f.info, where you can also find comparisons between each quarter. As always, 13F filings only mandate the declaration of long positions and the filings don’t require investors to reveal the price paid, strike price or expiration date of options purchased. Our top five holdings information comes to us from Whale Wisdom.
4 topics
31 stocks mentioned
1 fund mentioned